MDFA welcomes news that Ozurdex will be listed on the Pharmaceutical Benefits Scheme (PBS) from November 2016.
A National Eye Health Survey has identified that the prevalence of blindness and vision impairment in Australia has declined.
Jean Kittson lives with an increased risk of age-related macular degeneration. She’s also the carer for her elderly parents, who both have vision loss.
Erin has Stargardt’s disease, a rare genetic eye disease that generally first appears between the ages of 10 to 20.
Alicia has Stargardt’s disease, a hereditary eye condition that affects the macula. She shares her story and her positive attitude to life.
MDFA has provided a submission on behalf of our community to the Productivity Commission’s inquiry on human services reform.
The aim of the research project is to enhance the health and wellbeing of family carers of people with age-related macular degeneration.
Baby boomers, born between 1946 and 1965, are at risk of age-related macular degeneration, Australia’s leading cause of blindness and severe vision loss.